Prevention tips

Vaccination is the most important line of defense against the risks of contracting meningococcal disease1 —especially since it may be hard for your child to avoid all activities where respiratory secretions, throat secretions, or saliva is exchanged. But there are additional steps your child can take that may help prevent illness and protect their overall health:

  • Avoid sharing knives, forks, glasses, straws, food, lipstick, and other items that touch the mouth—they can all spread meningococcal bacteria1,2
  • Cover their mouth when coughing or sneezing
  • Wash hands frequently with warm water and soap before putting food in their mouth––and after they cough, sneeze, or use the bathroom
  • Eat healthy foods and avoid stress.3
  • Avoid smoking or being exposed to smoke
  • Spread the word about vaccination to family and friends who may be at risk

You may not be able to keep your kids from all these activities, but you can help protect them with a Menveo® vaccination

Indication

Menveo is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menveo is approved for use in persons 2 to 55 years of age. Menveo does not prevent N. meningitidis serogroup B infections.

Important Safety Information

You should not receive Menveo if you have had a severe allergic reaction to any ingredient of the vaccine, or if you have had a severe allergic reaction to a vaccine containing similar components as Menveo.

Side effects to Menveo include pain at the injection site, headache, muscle pain, fatigue, nausea, and fainting. Sometimes fainting is accompanied by falling with injury. Other side effects may occur.

Following vaccination with another US-licensed meningococcal conjugate vaccine, an evaluation of postmarketing adverse events suggested a potential for increased risk of Guillain-Barré Syndrome (GBS). There is not enough information to evaluate if a risk of GBS exists following administration of Menveo.

Tell your doctor if you are pregnant or planning to get pregnant.

Vaccination with Menveo may not protect all individuals.

For more information about Menveo, talk to your health-care professional.

Menveo.com has been developed by Novartis Vaccines as part of the company’s commitment to individual and public health.

References

  1. Meningitis: Prevention. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/meningitis/about/prevention.html. Accessed March 3, 2010.
  2. Meningococcal meningitis. World Health Organization Web site. http://www.who.int/mediacentre/factsheets/fs141/en/. Accessed March 3, 2010.
  3. Exercise – Colds and flu. MedlinePlus Web site. http://www.nlm.nih.gov/medlineplus/ency/article/002083.htm. Accessed March 3, 2010.
  4. Meningococcal: Questions and answers. Immunization Action Coalition Web site. http://www.immunize.org/catg.d/p4210.pdf. Accessed March 3, 2010.

Menveo.com Exit Notice

You are now leaving the Menveo.com site and moving to an external website independently operated and not managed by Novartis Vaccines and Diagnostics Inc. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or, click OK to continue.

OKCancel